Skip to main content

Three approaches for estimating prevalence of cancer with reversibility. Application to colorectal cancer

  • Conference paper
Probability, Statistics and Modelling in Public Health
  • 2120 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Brillinger, D.R.: The natural variability of vital rates and associated statistics (with discussion). Biometrics. 42, 693–734 (1986)

    MATH  MathSciNet  Google Scholar 

  2. Capocaccia, R., De Angelis, R.: Estimating the completeness of prevalence based on cancer registry data. Statistics in Medicine. 16, 425–440 (1997)

    Article  Google Scholar 

  3. Clegg, L.X., Gail, M.H., Feuer, E.J.: Estimating the variance of disease-prevalence. Estimates from population-based registries. Biometrics. 58, 684–688 (2002)

    Article  MathSciNet  Google Scholar 

  4. De Angelis, R., Capocaccia, R., Hakulinen, T., Soderman, B., Verdecchia, A.: Mixture models for cancer survival analysis: application population-based data with covariates. Statistics in Medicine. 18, 441–454 (1999)

    Google Scholar 

  5. DeGroot, M.H., Ferber, R., Frankel, M.R., Seneta, E., Watson, G.S.: Encyclopedia of statistical sciences. Wiley, New York (1988)

    Google Scholar 

  6. Dodge, Y.: Statistique Dictionnnaire encyclopédique. Dunod, Paris (1993)

    Google Scholar 

  7. Feldman, A.R., Kessler, L., Myers, M.H., Naughton, M.D.: The prevalence of cancer. Estimates based on the Connecticut Tumor Registry. New England Journal of Medicine. 315, 1394–1397 (1986)

    Google Scholar 

  8. Gail, M.H., Kessler, L., Midthune, D., Scoppa, S.: Two approaches for estimating disease prevalence from population-based registries of incidence and total mortality. Biometrics. 55, 1137–1144 (1999)

    Article  MathSciNet  Google Scholar 

  9. Gamel, J.W.: Proportion cured and mean long survival time as functions of tumor size. Statistics in Medicine. 9, 999–1006 (1990)

    Google Scholar 

  10. Goldman, A.I.: Survivorship analysis when cure is a possibility: a Monte carlo study. Statistics in Medicine. 3, 153–163 (1984)

    Google Scholar 

  11. Gras, C., Daures, J.P., Tretarre, B.: A computer software to estimate chronic disease age-and stage-specific incidence and prevalence using cancer registries data. In submission.

    Google Scholar 

  12. Keiding N.: Age-specific incidence and prevalence: A statistical perspective. Journal of the Royal Statistical Society, Series A. 154, 371–412 (1991)

    MATH  MathSciNet  Google Scholar 

  13. Maller R., Zhou, X.: Survival analysis with long-term survivors. Wiley, New York (1996)

    Google Scholar 

  14. Merrill, R.M., Capocaccia, R., Feuer, E.J., Mariotto, A.: Cancer Prevalence Estimates Based on Tumor Registry Data in the SEER Program. International Journal of Epidemiology. 29, 197–207 (2000)

    Article  Google Scholar 

  15. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence-SEER 9 Regs, Nov 2002 Sub (1973–2000), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2003, based on the November 2002 submission.

    Google Scholar 

  16. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Mortality-All COD, Public-Use With State, Total U.S. (1969–2000), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2003. Underlying mortality data provided by NCHS (www.cdc.gov/nchs).

    Google Scholar 

  17. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Populations-Total U.S. (1969–2000), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2003.

    Google Scholar 

  18. Verdecchia, A., Capocaccia, R.: A method for the estimation of chronic disease morbidity and trends from mortality data. Statistics in Medicine. 8, 201–216 (1989)

    Google Scholar 

  19. Verdecchia, A., De Angelis, R., Capocaccia, R., Sant, M., Micheli, A., Gatta, G., Berrino, F.: The cure for colon cancer: results from the EUROCARE study. International Journal of Cancer. 77, 322–329 (1998)

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Science+Business Media, Inc.

About this paper

Cite this paper

Gras, C., Daurès, J., Tretarre, B. (2006). Three approaches for estimating prevalence of cancer with reversibility. Application to colorectal cancer. In: Nikulin, M., Commenges, D., Huber, C. (eds) Probability, Statistics and Modelling in Public Health. Springer, Boston, MA. https://doi.org/10.1007/0-387-26023-4_12

Download citation

Publish with us

Policies and ethics